The in vitro diagnostics company UmanDiagnostics has gone from being a micro business to a small business. The company specializes in nerve injury markers and the Neurofilament light protein (NFL), which makes it easier to find and diagnose neurological diseases such as Multiple Sclerosis, ALS, and Alzheimer's disease.
"This expansion will enable us to increase productivity and deliver more products to the market”, says Niklas Norgren, VP and Managing Director.
Swedish-based UmanDiagnostics, a Quanterix company, has developed a new type of product that makes it easier to detect neurological diseases. Called NF-light ™ serum ELISA, it was officially launched on October 12th and will now be sold worldwide.
“Our product can be used for research inthe field of neurological diseases throughout the world. It feels very exciting, because our product is c
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.
Tvistevägen 48C
907 36 Umeå
Sweden